HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A phase II study of M-azido-pyrimethamine ethane sulphonate (MZPES) in advanced, recurrent soft tissue sarcoma. An EORTC Soft Tissue and Bone Sarcoma Group Study.

AuthorsG Blackledge, J Verweij, R Fuchs, H J Keizer, R Somers, E Rankin, P Kerbrat, A van Oosterom, R Sylvester, D Thomas
JournalEuropean journal of cancer & clinical oncology (Eur J Cancer Clin Oncol) Vol. 25 Issue 12 Pg. 1891-3 (Dec 1989) ISSN: 0277-5379 [Print] England
PMID2632271 (Publication Type: Journal Article)
Chemical References
  • Azides
  • 3-azidopyrimethamine
  • Pyrimethamine
Topics
  • Adult
  • Aged
  • Azides (adverse effects, therapeutic use)
  • Drug Evaluation
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Metastasis
  • Pyrimethamine (adverse effects, analogs & derivatives, therapeutic use)
  • Sarcoma (drug therapy)
  • Soft Tissue Neoplasms (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: